Strata Critical Medical, Inc. provides time-critical logistics and medical services to the healthcare industry in the United States. It operates in two segments, Logistics and Clinical. The company offers logistics services, such as air and ground transportation for human organs, transplant teams, and related medical materials and organ placement services; transplant clinical services, including organ recovery procedures, normothermic regional perfusion, and preservation services. It also provides other clinical services comprising cardiac perfusion services, blood management and autotransfusion services, extracorporeal membrane oxygenation services, perfusion staffing, and equipment rentals. The company was formerly known as Blade Air Mobility, Inc. and changed its name to Strata Critical Medical, Inc. in August 2025. The company was founded in 2014 and is headquartered in New York, New York.
Ticker
SRTA
Exchange
Nasdaq
Sector
Healthcare
Industry
Medical Care Facilities
Market cap
$490.81M
52-week range
$3.95 - $6.50
Valuation
Share price
$5.56 (close of Nov 6, 2026)
P/E (TTM)
-19.17x
Price to book
1.78x
Price to free cash flow
608.94x
Enterprise value
$459.29M
Book value per share
$3.13
Price performance
Period
Change
1 day
+5.70%
5 days
+25.23%
1 month
+17.05%
3 months
-0.54%
6 months
+4.32%
Year to date
+15.59%
1 year
+19.57%
3 years
+149.33%
5 years
-44.95%
All time
-42.97%
Short interest
As of
Oct 15, 2026
Short % of float
6.42%
Shares short
4.54M
Days to cover
5.00
Change since prior report
+4.76%
Source
FINRA consolidated short interest
Profitability and growth
Return on equity
14.82%
Return on invested capital
-7.92%
Return on assets
12.70%
Return on capital employed
-7.31%
Gross margin
20.86%
Net margin
20.97%
EBITDA margin
-7.19%
Revenue growth
34.28%
Cash flow and balance sheet
Free cash flow yield (TTM)
0.16%
Current ratio
2.77x
Net debt to EBITDA
-9.62x
Latest reported year
Period end
Dec 31, 2025
Fiscal year
2025
Revenue
$197.14M
Cost of revenue
$156.01M
Gross profit
$41.13M
EBITDA
-$14.17M
Net income
$41.35M
Earnings per share
$0.50
Shares outstanding
82.09M
Income statement by year
Period end
Revenue
Gross profit
Net income
EPS
2025-12-31
$197.14M
$41.13M
$41.35M
$0.50
2024-12-31
$146.82M
$29.59M
-$27.31M
-$0.35
2023-12-31
$225.18M
$42.12M
-$56.08M
-$0.76
2022-12-31
$146.12M
$22.27M
-$27.26M
-$0.38
2021-09-30
$50.53M
$10.52M
-$40.05M
-$0.93
2020-12-31
-
-
-$20.52M
-$2.17
2020-09-30
$23.43M
$2.33M
-$10.16M
-$0.40
2019-12-31
-
-
$2.33M
$0.19
2019-09-30
$31.20M
$4.70M
-$10.84M
-$0.43
Margins and returns by year
Period end
Gross margin
Net margin
Return on equity
Return on capital
2025-12-31
20.86%
20.97%
14.82%
-7.92%
2024-12-31
20.15%
-18.60%
-12.30%
-10.01%
2023-12-31
18.71%
-24.90%
-23.93%
-25.75%
2022-12-31
15.24%
-18.66%
-9.93%
-18.02%
2021-09-30
20.82%
-79.27%
-13.75%
-7.01%
2020-12-31
-
-
-
-13.57%
2020-09-30
9.93%
-43.36%
-91.70%
-87.78%
2019-12-31
-
-
-
46.63%*
2019-09-30
15.06%
-34.74%
-52.27%
-
* Estimated EBIT: pre-tax income + net interest. This company reports no operating income line.